![](/img/cover-not-exists.png)
Epigallocatechin-3-gallate (EGCG) inhibits PC-3 prostate cancer cell proliferation via MEK-independent ERK1/2 activation
Daniel S. Albrecht, Elizabeth A. Clubbs, Mario Ferruzzi, Joshua A. BomserVolume:
171
Year:
2008
Language:
english
Pages:
7
DOI:
10.1016/j.cbi.2007.09.001
File:
PDF, 358 KB
english, 2008